Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

10X Genomics Inc

TXG
Current price
13.34 USD -0.71 USD (-5.05%)
Last closed 14.12 USD
ISIN US88025U1097
Sector Healthcare
Industry Health Information Services
Exchange NASDAQ
Capitalization 1 893 284 608 USD
Yield for 12 month -66.60 %
1Y
3Y
5Y
10Y
15Y
TXG
21.11.2021 - 28.11.2021

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. Address: 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

20.2 USD

P/E ratio

Dividend Yield

Current Year

+618 727 000 USD

Last Year

+516 409 000 USD

Current Quarter

+151 654 000 USD

Last Quarter

+153 104 000 USD

Current Year

+409 313 000 USD

Last Year

+396 023 000 USD

Current Quarter

+106 393 000 USD

Last Quarter

+106 896 000 USD

Key Figures TXG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -134 768 992 USD
Operating Margin TTM -27.36 %
PE Ratio
Return On Assets TTM -11.37 %
PEG Ratio
Return On Equity TTM -24.87 %
Wall Street Target Price 20.2 USD
Revenue TTM 629 742 976 USD
Book Value 5.97 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.3 %
Dividend Yield
Gross Profit TTM 396 023 000 USD
Earnings per share -1.52 USD
Diluted Eps TTM -1.52 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -28.99 %

Dividend Analytics TXG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TXG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:2
Payout Ratio
Last Split Date 17.07.2006
Dividend Date

Stock Valuation TXG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 196.0784
Enterprise Value Revenue 2.5106
Price Sales TTM 3.0064
Enterprise Value EBITDA -40.6858
Price Book MRQ 2.6194

Financials TXG

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TXG

For 52 weeks

14.02 USD 57.9 USD
50 Day MA 19.22 USD
Shares Short Prior Month 7 437 142
200 Day MA 26.74 USD
Short Ratio 3.53
Shares Short 7 652 761
Short Percent 8.28 %